VAD-PECC regimen in the treatment of advanced-stage multiple myeloma.
Delain, M
VAD-PECC regimen in the treatment of advanced-stage multiple myeloma. [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology Dec 1994 - 2706-13 p. digital
Publication Type: Clinical Trial; Journal Article; Multicenter Study
0732-183X
10.1200/JCO.1994.12.12.2706 doi
Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Carmustine--administration & dosage
Cyclophosphamide--administration & dosage
Dexamethasone--administration & dosage
Doxorubicin--administration & dosage
Female
Follow-Up Studies
Humans
Male
Middle Aged
Multiple Myeloma--drug therapy
Neoplasm Staging
Prednisone--administration & dosage
Prognosis
Prospective Studies
Regression Analysis
Survival Analysis
Treatment Outcome
Vincristine--administration & dosage
Vindesine--administration & dosage
VAD-PECC regimen in the treatment of advanced-stage multiple myeloma. [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology Dec 1994 - 2706-13 p. digital
Publication Type: Clinical Trial; Journal Article; Multicenter Study
0732-183X
10.1200/JCO.1994.12.12.2706 doi
Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Carmustine--administration & dosage
Cyclophosphamide--administration & dosage
Dexamethasone--administration & dosage
Doxorubicin--administration & dosage
Female
Follow-Up Studies
Humans
Male
Middle Aged
Multiple Myeloma--drug therapy
Neoplasm Staging
Prednisone--administration & dosage
Prognosis
Prospective Studies
Regression Analysis
Survival Analysis
Treatment Outcome
Vincristine--administration & dosage
Vindesine--administration & dosage